{{Rsnum
|rsid=13091637
|Gene=ATR
|Chromosome=3
|position=142547597
|Orientation=plus
|GMAF=0.1497
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ATR
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 67.3 | 30.0 | 2.7
| HCB | 60.7 | 33.3 | 5.9
| JPT | 69.4 | 27.9 | 2.7
| YRI | 91.7 | 8.3 | 0.0
| ASW | 83.9 | 16.1 | 0.0
| CHB | 60.7 | 33.3 | 5.9
| CHD | 71.0 | 26.2 | 2.8
| GIH | 65.0 | 34.0 | 1.0
| LWK | 92.6 | 7.4 | 0.0
| MEX | 63.2 | 35.1 | 1.8
| MKK | 85.9 | 14.1 | 0.0
| TSI | 66.0 | 32.0 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20513533
|Title=Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population
}}

{{PMID Auto
|PMID=17010193
|Title=Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}